Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1130 | 974 | 1130 | 1180 | 1562 | 2810 |
Fund Return | 13.02% | -2.59% | 13.02% | 5.66% | 9.33% | 10.88% |
Place in category | 1560 | 1768 | 1560 | 884 | 612 | 101 |
% in Category | 88 | 95 | 88 | 59 | 51 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CI Black Creek Global Leaders D | 4.86B | 12.23 | 4.92 | 10.11 | ||
CI Signature Select Canadian Class | 2.81B | 20.97 | 7.91 | 9.21 | ||
CI Cambridge Canadian Dividend F | 1.77B | 19.03 | 7.38 | 9.58 | ||
CI Cambridge Canadian Div E CAD | 1.77B | 17.86 | 6.32 | 8.49 | ||
CI Cambridge Canadian Dividend D | 1.77B | 18.19 | 6.63 | 8.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.83B | 60.55 | 18.32 | - | ||
Capital Group Glbal Equity Fd F CAD | 14.38B | 28.47 | 5.35 | 11.90 | ||
Capital Group Glbal Equity Fd A CAD | 14.38B | 27.06 | 4.20 | 10.67 | ||
Capital Group Glbal Equity Fd D CAD | 14.38B | 28.08 | 5.00 | 11.43 | ||
Mawer Global Equity | 10.54B | 10.72 | 4.79 | 10.63 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NEC Corp. | JP3733000008 | 5.70 | 15,525.0 | +18.38% | |
Ebara Corp. | JP3166000004 | 5.24 | 2,579.5 | +0.10% | |
Kuehne & Nagel | CH0025238863 | 5.06 | 207.60 | -0.76% | |
Kerry Group | IE0004906560 | 4.92 | 99.15 | -1.05% | |
Elanco Animal Health | US28414H1032 | 4.88 | 12.03 | -3.53% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Sell | BUY |
Summary | Strong Buy | Neutral | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review